These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17664878)

  • 21. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
    Fleischer AB; Abramovits W; Breneman D; Jaracz E;
    J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
    Panahi Y; Moharamzad Y; Beiraghdar F; Naghizadeh MM
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):171-5. PubMed ID: 19143752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
    Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
    Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
    Boms S; Gambichler T; Freitag M; Altmeyer P; Kreuter A
    BMC Dermatol; 2004 Oct; 4(1):14. PubMed ID: 15485581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
    Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T
    Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low systemic exposure in infants with atopic dermatitis in a 1-year pharmacokinetic study with pimecrolimus cream 1%*.
    Lakhanpaul M; Davies T; Allen BR; Schneider D
    Exp Dermatol; 2006 Feb; 15(2):138-41. PubMed ID: 16433686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
    Staab D; Pariser D; Gottlieb AB; Kaufmann R; Eichenfield LF; Langley RG; Scott G; Ebelin ME; Barilla D; Schmidli H; Burtin P
    Pediatr Dermatol; 2005; 22(5):465-71. PubMed ID: 16191004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
    Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
    Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
    Lonsdale-Eccles AA; Velangi S
    Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
    Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
    J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood.
    Passeron T; Lacour JP; Fontas E; Ortonne JP
    Arch Dermatol; 2007 Apr; 143(4):472-6. PubMed ID: 17438179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lichen striatus in adults and pimecrolimus: open, off-label clinical study.
    Campanati A; Brandozzi G; Giangiacomi M; Simonetti O; Marconi B; Offidani AM
    Int J Dermatol; 2008 Jul; 47(7):732-6. PubMed ID: 18613885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus.
    Tlacuilo-Parra A; Guevara-Gutiérrez E; Gutiérrez-Murillo F; Soto-Ortiz A; Barba-Gómez F; Hernández-Torres M; Salazar-Páramo M
    Rheumatology (Oxford); 2005 Dec; 44(12):1564-8. PubMed ID: 16159951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of pimecrolimus cream 1% in the daily practice: results of a patient self-observation study in patients with atopic dermatitis.
    Luger TA; Gollnick H; Schwennesen T; Bextermöller R; Freytag S; Bräutigam M
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):908-14. PubMed ID: 17910673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.